{"nct_id":"NCT01767766","title":"Evaluate the Safety and Efficacy of TGR 1202 in Patients With Relapsed or Refractory Hematologic Malignancies","status":"COMPLETED","status_verified_date":"2021-08","start_date":"2013-01-07","start_date_type":"ACTUAL","primary_completion_date":"2018-02","primary_completion_date_type":"ACTUAL","completion_date":"2018-02","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["TGTX"]}